![Luis Peña](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Luis Peña
Fondateur chez
EVOMMUNE, INC.
Fortune : 15 M $ au 31/05/2026
Profil
Luis C.
Peña was the founder of Dermira, Inc., founded in 2010, where the title held was Chief Development Officer.
Mr. Peña is the founder of Evommune, Inc., founded in 2020, holding the titles of President, Chief Executive Officer & Director.
Former jobs include Senior Director-Project Planning & Management at Innoviva, Inc., Principal at Genentech, Inc., Vice President-Portfolio Planning & Management at Connetics Corp.
from 2005 to 2007, Vice President-Product Development at Nuvelo, Inc. from 2001 to 2005, and VP & Head-Global Prescription Development at Stiefel Laboratories, Inc. from 2010 to 2011.
Education includes undergraduate studies at San Francisco State University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
EVOMMUNE, INC. 1,77% | 01/06/2026 | 637 896 ( 1,77% ) | 15 M $ | 31/05/2026 |
Postes actifs de Luis Peña
| Sociétés | Poste | Début |
|---|---|---|
| EVOMMUNE, INC. | Fondateur | 01/04/2020 |
Anciens postes connus de Luis Peña
| Sociétés | Poste | Fin |
|---|---|---|
Stiefel Laboratories, Inc.
 Stiefel Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/03/2011 |
Connetics Corp.
 Connetics Corp. BiotechnologyHealth Technology Develops and commercializes dermatology products | Corporate Officer/Principal | 01/01/2007 |
Nuvelo, Inc.
 Nuvelo, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using genomic technologies | Corporate Officer/Principal | 01/01/2005 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
| INNOVIVA, INC. | Corporate Officer/Principal | - |
Formation de Luis Peña
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
60
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Connetics Corp.
Connetics Corp. BiotechnologyHealth Technology Develops and commercializes dermatology products | Health Technology |
Nuvelo, Inc.
Nuvelo, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using genomic technologies | Health Technology |
Innoviva, Inc.
 Innoviva, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that manufactures respiratory drugs | Health Technology |
San Francisco State University
 San Francisco State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stiefel Laboratories, Inc.
Stiefel Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Dermira, Inc.
 Dermira, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products to patients living with chronic skin conditions | Health Technology |
Evommune, Inc.
 Evommune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops therapies for chronic inflammatory diseases | Health Technology |
